Quest Non Currrent Assets Other from 2010 to 2024

DGX Stock  USD 161.51  1.15  0.71%   
Quest Diagnostics Non Currrent Assets Other yearly trend continues to be fairly stable with very little volatility. Non Currrent Assets Other will likely drop to about 176 M in 2024. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
1996-09-30
Previous Quarter
216 M
Current Value
272 M
Quarterly Volatility
79.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of Quest Diagnostics Incorporated over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Quest Diagnostics' Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Pretty Stable
   Non Currrent Assets Other   
       Timeline  

Quest Non Currrent Assets Other Regression Statistics

Arithmetic Mean192,034,849
Geometric Mean164,391,588
Coefficient Of Variation60.89
Mean Deviation70,776,767
Median174,000,000
Standard Deviation116,929,109
Sample Variance13672.4T
Range529.5M
R-Value(0.27)
Mean Square Error13662.3T
R-Squared0.07
Significance0.33
Slope(7,021,396)
Total Sum of Squares191413.8T

Quest Non Currrent Assets Other History

2024176 M
2023198 M
2022144 M
2021163 M
2020176 M
2019160 M
2018119 M

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Currrent Assets Other198 M176 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.